A detailed history of Illinois Municipal Retirement Fund transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Illinois Municipal Retirement Fund holds 29,124 shares of PTGX stock, worth $1.14 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,124
Holding current value
$1.14 Million
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$33.72 - $47.33 $982,061 - $1.38 Million
29,124 New
29,124 $1.31 Million

Others Institutions Holding PTGX

About Protagonist Therapeutics, Inc


  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $1.93B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Illinois Municipal Retirement Fund Portfolio

Follow Illinois Municipal Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Illinois Municipal Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Illinois Municipal Retirement Fund with notifications on news.